USCarePharm Co., Ltd., a leader in natural material-based R&D, announced its recent presentation of new research on vascular health functional ingredients at the Annual Conference of the Korean Society of Pharmacognosy.

During the academic forum, USCarePharm unveiled the results of its advanced research into plant-derived bioactive compounds that demonstrated efficacy in supporting vascular wall integrity and circulatory health. The study focused on a newly identified material, USCP0112, which showed promise in improving endothelial function, reducing oxidative stress, and modulating lipid metabolism — all crucial factors in vascular wellness.

This achievement is part of USCarePharm’s broader UMAP Tech™ platform, which specializes in the systematic discovery, screening, and optimization of high-performance natural ingredients for use in pharmaceuticals, functional foods, and cosmeceuticals.

“The results we shared reflect years of targeted research in functional ingredients derived from traditional medicinal plants,” said CEO Song Seok-jin.
“We are committed to transforming these findings into clinically meaningful applications that promote cardiovascular wellness and overall health.”

The presentation further strengthens USCarePharm’s reputation as a pioneer in bio-convergent healthcare innovation, capable of bridging the gap between traditional natural remedies and scientifically validated modern therapeutics.

USCarePharm plans to continue collaboration with academic institutions and industry partners to accelerate the commercialization of science-based natural health solutions.